跳至主要内容
临床试验/NCT01675362
NCT01675362已完成4 期

A Randomized Controlled Trial for Evaluating Protective Effects of Antioxidants (Selenium and Vitamins A, C and E), Calcium Channel Blocker (Verapamil) and Angiotensin Receptor Blocker (Losartan) Against Extracorporeal Shockwaves Lithotripsy Induced Renal Injury

Mansoura University1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2012年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
160
试验地点
1
主要终点
Renal damage

研究概览

简要总结

This study will be conducted to evaluate the protective effects and mechanisms of antioxidants (vitamins A, C, E and Selenium), calcium channel blocker (Verapamil) and angiotensin receptor blocker (Lozartan) against shock wave induced renal injuries.

详细描述

The protective effect will be evaluated via estimation of the changes in renal tubular enzyme (NGAL) and detection of albumen levels in urine. The mechanisms of protection will be investigated by estimation of renal perfusion and functional changes using dynamic MRI.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Well functioning kidney (serum creatinine <1.2 mg/dl).
  • Solitary renal stone.
  • Size: 25 mm or less in the largest diameter.

排除标准

  • Contraindications to ESWL
  • Previous surgical treatment of renal stones.
  • Congenital renal anomalies.
  • Pediatric patients (age <18 years).
  • Patients with Diabetes or hypertension

研究组 & 干预措施

Control group

Placebo Comparator

They will receive placebo

干预措施: Placebo (Drug)

Antioxidant group

Active Comparator

They will be receive vitamins A, C, E and selenium (Selenium ACE) Dosage: Two tablets before ESWL Then 2 tablets every 8 hours after ESWL for one week

干预措施: Antioxidant group (Drug)

Calcium channel Blockers

Active Comparator

They will receive Verapamil (Isoptin 80 mg) Dosage: One tablet 2 hours before ESWL Then one tablet every 12 hours after ESWL for one week

干预措施: Calcium Channel Blockers (Drug)

Angiotensin receptor blocker group

Active Comparator

They will receive Losartan (Cozaar 50 mg) Dosage: One tablet 2 hours before ESWL Then one tablet every day after ESWL for one week

干预措施: Angiotensin receptor blocker group (Drug)

结局指标

主要结局

Renal damage

时间窗: two hours and one week after Extracorporeal shock wave lithotripsy (ESWL)

The protective effect will be evaluated via estimation of the changes in renal tubular enzyme (NGAL) and detection of albumen levels in urine.

次要结局

  • The mechanisms of renal protection(Before ESWL, 2 hours and 1 week after ESWL)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed R. EL-Nahas

Assistant Professor of Urology

Mansoura University

研究点 (1)

Loading locations...

相似试验